Houston, TX 的 潰瘍性結腸炎 臨床試驗
17 項針對 潰瘍性結腸炎 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · 距離 7 英里
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Baylor College of Medicine, Houston
- Intergrity Research, Houston
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
招募中1/2 期歡迎健康志工
- Xencor Investigative Site, Houston
- Xencor Investigative Site, Houston
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Site US-030, Houston
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Victorium Clinical Research, Houston
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
招募中2/3 期
- Texas Children's Hospital, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- UT MD Anderson Cancer Center, Houston
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Integrity Advanced Therapeutics, Houston
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
招募中4 期
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
招募中觀察性研究
- BAMC, Houston
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
招募中2 期
- Baylor College of Medicine, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
招募中
- Baylor College of Medicine, Houston
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
招募中觀察性研究
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
招募中觀察性研究
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
招募中3 期
- Texas Children's Hospital - Baylor - PIN, Houston
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Houston
其他城市的 潰瘍性結腸炎 試驗
- New York City, NY23 項研究
- Orlando, FL22 項研究
- Miami, FL21 項研究
- San Antonio, TX16 項研究
- Tacoma, WA15 項研究
- Chicago, IL15 項研究
- San Diego, CA15 項研究
- Tyler, TX14 項研究
- Colorado Springs, CO14 項研究
- Los Angeles, CA13 項研究
- St. Louis, MO13 項研究
- Washington, DC12 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。